Market closed

Curis/$CRIS

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Curis

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Ticker

$CRIS

Sector

Health Care

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Lexington, United States

Employees

Website

www.curis.com

Curis Metrics

BasicAdvanced

$28M

-

-$7.80

3.35 -

Price and volume

Market cap

$28M

Beta

3.35

52-week high

$17.49

52-week low

$2.86

Average daily volume

184K

Financial strength

Current ratio

1.223

Quick ratio

1.082

Long term debt to equity

-333.99

Total debt to equity

-449.33

Interest coverage (TTM)

-268.24%

Management effectiveness

Return on assets (TTM)

-45.06%

Return on equity (TTM)

-436.16%

Valuation

Price to revenue (TTM)

1.91

Price to book

-2.32

Price to tangible book (TTM)

-1.14

Price to free cash flow (TTM)

-0.484

Growth

Revenue change (TTM)

0.44%

Earnings per share change (TTM)

-16.16%

3-year revenue growth (CAGR)

-0.89%

3-year earnings per share growth (CAGR)

-5.47%

What the Analysts think about Curis

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Curis stock.

Curis Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Curis Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Curis News

AllArticlesVideos

Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CRIS

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Curis stock?

Curis (CRIS) has a market cap of $28M as of January 15, 2025.

What is the P/E ratio for Curis stock?

The price to earnings (P/E) ratio for Curis (CRIS) stock is 0 as of January 15, 2025.

Does Curis stock pay dividends?

No, Curis (CRIS) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Curis dividend payment date?

Curis (CRIS) stock does not pay dividends to its shareholders.

What is the beta indicator for Curis?

Curis (CRIS) has a beta rating of 3.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.